Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Finasteride Treatment of Severe Nodulocystic Acne

ClinicalTrials.gov ID: NCT02502669

Public ClinicalTrials.gov record NCT02502669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Double-blind, randomized, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of once weekly, high dose oral finasteride compared to placebo for the treatment of severe nodulocystic acne in male subjects.

Study identification

NCT ID
NCT02502669
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Elorac, Inc.
Industry
Enrollment
106 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 35 Years
Sex
Male
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2015 (Type not available)
Primary completion
Jun 6, 2017 (Actual)
Completion
Jun 6, 2017 (Actual)
Last update posted
Feb 15, 2019

2015 – 2017

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Omni Dermatology, Inc. Phoenix Arizona 85018 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Dr. Ronald Moy Beverly Hills California 90210 —
Axis Clinical Trials Los Angeles California 90036 —
Orange County Research Center Tustin California 92780 —
Horizons Clinical Research Center, LLC. Denver Colorado 80220 —
MOORE Clinical Research, Inc. Brandon Florida 33511 —
Advanced Medcial Research Institiute Miami Lakes Florida 33174 —
Park Avenue Dermatology Orange Park Florida 32073 —
International Clinical Research Sanford Florida 32771 —
Lenus Research & Medical Group Sweetwater Florida 33172 —
Marietta Dermatology Clinical Research, Inc. Marietta Georgia 30060 —
MedaPhase, Inc. Newnan Georgia 30263 —
Northwest Clinical Trials Boise Idaho 83704 —
Glazer Dermatology Buffalo Grove Illinois 60089 —
Northwestern University Chicago Illinois 60611 —
Summit Dermatology Oakbrook Terrace Illinois 60181 —
Dawes Fretzin Clinical Research Group. LLC Indianapolis Indiana 46256 —
The Indiana Clinical Trials Center, PC Plainfield Indiana 46168 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
MediSearch Clinical Trials Saint Joseph Missouri 64506 —
Greenwich Village Dermatology New York New York 10012 —
UHCMC Skin Study Center Cleveland Ohio 44106 —
Paddington Testing Co., Inc. Philadelphia Pennsylvania 19103 —
Invocare Clinical Research Center West Columbia South Carolina 29169 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02502669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 15, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02502669 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →